Educational content, not medical advice. This article explains published gene-behavior research for general education. It is not a diagnosis, treatment, or prevention claim, and genotype is never destiny. Talk to a licensed clinician or genetic counselor before making any health decision.
The MAOA gene and COMT gene are two of the most-cited "mood genes" in behavioral genetics — and also two of the most misunderstood. One controls how fast you clear dopamine and other catecholamines; the other, nicknamed the "warrior gene," has a media reputation that outpaces the actual science. Here's what the data supports, and what it doesn't.
Key Takeaway
The COMT gene (rs4680, Val158Met) controls how quickly your body clears dopamine and catecholamines from the prefrontal cortex. Met/Met ("slow COMT") clears dopamine slowly, leading to higher baseline dopamine and catecholamine levels and greater sensitivity to methyl donors and stimulants. Val/Val ("fast COMT") clears it quickly, for lower baseline dopamine. Val/Met sits in between. The MAOA gene is X-linked; its low-activity promoter variant (MAOA-L, popularly called the "warrior gene") breaks down serotonin, dopamine, and norepinephrine more slowly. Despite the nickname, MAOA-L does not determine aggression — decades of research show it only correlates with behavioral differences in combination with early-life adversity (a gene-environment interaction, not a standalone predictor). When slow COMT and MAOA-L occur together, catecholamine clearance is doubly slow, which is one reason some people report heightened sensitivity to methyl donors like methylfolate — a topic worth discussing with a clinician rather than self-diagnosing.
What Is the MAOA Gene?
The MAOA gene sits on the X chromosome and codes for monoamine oxidase A, an enzyme that breaks down serotonin, dopamine, and norepinephrine after they've done their job in the synapse. A variable-number tandem repeat in the MAOA promoter region (MAOA-uVNTR) determines how much of this enzyme gets made.
Variants are generally grouped into high-activity and low-activity categories. The low-activity variant — MAOA-L — produces less enzyme, meaning serotonin, dopamine, and norepinephrine are broken down more slowly and may linger longer in the synapse.
Is the Warrior Gene Real?
The "warrior gene" nickname stuck to MAOA-L after early 2000s studies linked it to aggressive behavior in some populations. It's a catchy label — and also an oversimplification that the original researchers themselves have pushed back against.
The nuanced finding is a gene-environment interaction: MAOA-L has been associated with higher rates of antisocial or aggressive behavior only in individuals who also experienced significant childhood maltreatment or adversity. In the absence of that environmental factor, MAOA-L carriers show no consistent behavioral difference from high-activity carriers. In other words, genotype alone does not predict behavior — the "warrior gene" framing skips the environmental half of the equation entirely, and no single gene determines personality or conduct.
How Does COMT Affect Dopamine?
COMT (catechol-O-methyltransferase) is an enzyme that breaks down dopamine and other catecholamines, and it's especially important for clearing dopamine in the prefrontal cortex — the brain region tied to focus, planning, and stress response. The rs4680 variant (Val158Met) changes how efficiently this enzyme works.
- Met/Met ("slow COMT") — the enzyme works slowly, so dopamine and catecholamines clear gradually and accumulate at higher baseline levels. This genotype is often linked with greater sensitivity to methyl donors and stimulants.
- Val/Val ("fast COMT") — the enzyme works efficiently, clearing dopamine quickly and keeping baseline catecholamine levels lower.
- Val/Met — an intermediate profile, with enzyme activity and catecholamine clearance somewhere between the two homozygous types.
This is a core piece of COMT dopamine biology: it's not about how much dopamine you produce, it's about how efficiently you clear it once it's released.
Slow vs. Fast COMT — What Should I Do?
Neither slow nor fast COMT is "better" — they're different clearance profiles with different trade-offs, and COMT genotype should never be treated as a diagnosis or a reason to self-medicate. That said, here are examples of questions people with each genotype often bring to a clinician:
- Slow COMT (Met/Met): "Given my higher baseline catecholamine levels, should I be cautious about methyl-donor supplements or stimulant dosing?" This is a starting point to discuss with your clinician — not a directive to avoid anything on your own. For more on this, see our guide on slow COMT supplements — what to take and avoid.
- Fast COMT (Val/Val): "Could my lower baseline dopamine clearance profile explain why I tolerate stimulants or methyl donors differently than others?" Again, an example question to explore with a professional, not a self-directed protocol.
- Either genotype: If you're also researching methylation status, our guide to methylfolate and L-methylfolate forms for MTHFR covers related terrain in more depth.
Want to see how your own variants line up? Ask your own DNA lets you query your COMT and MAOA results directly and bring specific, informed questions to your next clinical conversation.
How Do MAOA and COMT Interact?
Because COMT and MAOA both act on the same catecholamines — just at different points in the clearance pathway — their combined effect matters more than either gene alone. COMT clears dopamine in the synapse; MAOA breaks down dopamine, serotonin, and norepinephrine more broadly, including in the body.
When slow COMT (Met/Met) and MAOA-L occur together, both systems responsible for clearing catecholamines are running slower than average. This "doubly slow" clearance pattern is one reason people with this combination sometimes report heightened sensitivity to methyl donors, and it overlaps with the broader concept of overmethylation. If you're exploring this combination, our guide on overmethylation symptoms, causes, slow COMT, and MTHFR walks through the connected biology in more detail.
Again: this interaction describes a biochemical clearance pattern, not a behavioral or personality prediction. Two people with identical MAOA and COMT genotypes can have completely different temperaments, shaped by environment, upbringing, and countless other genes.
FAQ
Does the MAOA gene cause aggression? No single gene causes aggression. Research on MAOA-L shows an association with aggressive or antisocial behavior only when combined with significant early-life adversity — a gene-environment interaction, not a direct cause. Most MAOA-L carriers show no behavioral difference at all.
What does "warrior gene" mean? "Warrior gene" is a popular nickname for the low-activity MAOA-uVNTR variant (MAOA-L), coined after early studies linked it to aggression in specific contexts. The nickname is widely considered misleading because it implies determinism the research doesn't support.
Is slow COMT (Met/Met) bad for me? No — slow COMT isn't a disorder, it's a metabolic variant. It's linked to slower catecholamine clearance and higher sensitivity to methyl donors and stimulants for some people, which is worth discussing with a clinician, not something to self-treat.
How does COMT affect dopamine levels? COMT breaks down dopamine and other catecholamines, particularly in the prefrontal cortex. Slow COMT (Met/Met) clears dopamine gradually, keeping baseline levels higher; fast COMT (Val/Val) clears it quickly, keeping levels lower.
Can I test my own MAOA and COMT genotype? If you already have raw genetic data, you can look up your MAOA and COMT (rs4680) results and explore what they mean with a tool like Ask My DNA, then bring the findings to a clinician for personalized guidance.
Should I avoid methyl donors if I have slow COMT and MAOA-L? This is a common example question to raise with a clinician, not a rule to follow on your own. Individual tolerance varies, and any supplement decision should be made with professional guidance based on your full health picture.
Reminder: Genetic variants describe tendencies in biochemical pathways, not fixed outcomes. Nothing in this article diagnoses, treats, prevents, or cures any condition. Always consult a qualified healthcare provider before changing supplements, medications, or health decisions based on genetic information.